1. Home
  2. FHTX vs IBEX Comparison

FHTX vs IBEX Comparison

Compare FHTX & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FHTX
  • IBEX
  • Stock Information
  • Founded
  • FHTX 2015
  • IBEX 2017
  • Country
  • FHTX United States
  • IBEX United States
  • Employees
  • FHTX N/A
  • IBEX N/A
  • Industry
  • FHTX Medicinal Chemicals and Botanical Products
  • IBEX EDP Services
  • Sector
  • FHTX Health Care
  • IBEX Technology
  • Exchange
  • FHTX Nasdaq
  • IBEX Nasdaq
  • Market Cap
  • FHTX 237.4M
  • IBEX 267.7M
  • IPO Year
  • FHTX 2020
  • IBEX 2020
  • Fundamental
  • Price
  • FHTX $5.23
  • IBEX $25.69
  • Analyst Decision
  • FHTX Strong Buy
  • IBEX Buy
  • Analyst Count
  • FHTX 6
  • IBEX 2
  • Target Price
  • FHTX $13.17
  • IBEX $25.00
  • AVG Volume (30 Days)
  • FHTX 163.3K
  • IBEX 226.8K
  • Earning Date
  • FHTX 03-06-2025
  • IBEX 02-06-2025
  • Dividend Yield
  • FHTX N/A
  • IBEX N/A
  • EPS Growth
  • FHTX N/A
  • IBEX 37.48
  • EPS
  • FHTX N/A
  • IBEX 2.13
  • Revenue
  • FHTX $25,515,000.00
  • IBEX $521,725,000.00
  • Revenue This Year
  • FHTX N/A
  • IBEX $6.47
  • Revenue Next Year
  • FHTX $8.30
  • IBEX $4.29
  • P/E Ratio
  • FHTX N/A
  • IBEX $12.05
  • Revenue Growth
  • FHTX N/A
  • IBEX 1.66
  • 52 Week Low
  • FHTX $3.86
  • IBEX $13.00
  • 52 Week High
  • FHTX $10.25
  • IBEX $27.83
  • Technical
  • Relative Strength Index (RSI)
  • FHTX 52.39
  • IBEX 64.72
  • Support Level
  • FHTX $3.89
  • IBEX $25.70
  • Resistance Level
  • FHTX $6.27
  • IBEX $27.83
  • Average True Range (ATR)
  • FHTX 0.59
  • IBEX 1.09
  • MACD
  • FHTX 0.11
  • IBEX 0.14
  • Stochastic Oscillator
  • FHTX 48.38
  • IBEX 67.72

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

Share on Social Networks: